Ethnopharmacology of human immunodeficiency virus in South Africa - A minireview

African Journal of Biotechnology

Volumn 5, Issue 19, 2006, Pages 1693-1699

  Bessong, Pascal Obong ^a   Obi, Chikwelu Larry ^a  

^a UNIVERSITY OF VENDA   (South Africa)

Author keywords

Human immunodeficiency virus; Medicinal plants; South Africa

Indexed keywords

ACACIA NILOTICA EXTRACT; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; ANTIRETROVIRUS AGENT; BRIDELIA MICRANTHA EXTRACT; CATECHIN; COMBRETUM HARTMANNIANUM EXTRACT; COMBRETUM PANICULATUM EXTRACT; DODONAEA ANGUSTIFOLIA EXTRACT; ELAENDENDRON TRANVAALENSIS EXTRACT; EUPHORBIA EXTRACT; EUPHORBIA GRANULATA EXTRACT; GLYCYRRHIZIC ACID; HERBACEOUS AGENT; LEBOSTOMON TRIGONUS EXTRACT; MAYTENUS SENEGALENSIS EXTRACT; MICHELLAMINE A; MICHELLAMINE B; MICHELLAMINE C; MUCUNA CORIACEA EXTRACT; PAPAVARINE; PELTOPHORUM AFRICANUM EXTRACT; PLANT EXTRACT; PUTRANJIVAIN A; RICINUS COMMUNIS EXTRACT; SUTHERLANDIA FRUTESCENS EXTRACT; TANNIN; TERMINALIA SERICEA EXTRACT; TITHONIA DIVERSIFOLIA EXTRACT; TRICHOSANTHIN; UNCLASSIFIED DRUG; UNINDEXED DRUG;

ACACIA; ACACIA NILOTICA; ACQUIRED IMMUNE DEFICIENCY SYNDROME; BRIDELIA MICRANTHA; COMBRETUM; COMBRETUM HARTMANNIANUM; COMBRETUM PANICULATUM; DODONAEA ANGUSTIFOLIA; DRUG IDENTIFICATION; DRUG ISOLATION; DRUG MECHANISM; ELAENDENDRON TRANVAALENSIS; ENZYME INHIBITION; ETHNOPHARMACOLOGY; EUPHORBIA; EUPHORBIA GRANULATA; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; HUMAN IMMUNODEFICIENCY VIRUS PREVALENCE; LEBOSTOMON TRIGONUS; MAYTENUS; MAYTENUS SENEGALENSIS; MEDICINAL PLANT; MUCUNA CORIACEA; NONHUMAN; PELTOPHORUM AFRICANUM; REVIEW; RICINUS COMMUNIS; SOUTH AFRICA; SUTHERLANDIA FRUTESCENS; TERMINALIA SERICEA; TITHONIAN; TITHONIAN DIVERSIFOLIA;

HUMAN IMMUNODEFICIENCY VIRUS;

EID: 33751229624     PISSN: 16845315     EISSN: 16845315     Source Type: Journal    
DOI: None     Document Type: Review

References (41)

1. Ali H, Konig GM, Khalid SA, Wright AD, Kaminsky R (2002). Evaluation of selected Sudanese medicinal plants for their in vitro activity against hemoflagellates, selected bacteria, HIV-1-RT and tyrosine kinase inhibitory, and for cytotoxicity. J. Ethnopharmacol. 83(3): 219-28.
2. Asres K, Bucar F, Kartnig T, Witvrouw M, Pannecouque C, DeClercq E (2001). Antiviral activity against human immunodeficiency virus type 1 (HIV-1) and type 2 (HIV-2) of ethnobotanically selected Ethiopian medicinal plants. Phytother. Res. 15(1): 62-9.
3. Bessong PO, Obi CL, Andreolar M-L, Rojas LB, Pouysegu L, Igumbor E, Meyer JJM, Guideau S, Litvak S (2004). In vitro activity of three selected South African medicinal plants against human immunodeficiency virus type 1 reverse transcriptase. Afr. J. Biotechnol. 3(10): 555-559.
4. Bessong PO, Obi CL, Andreolar M-L, Rojas LB, Pouysegu L, Igumbor E, Meyer JJM, Guideau S, Litvak S (2005). Evaluation of selected South African medicinal plants for inhibitory properties against human immunodeficiency virus type 1 reverse transcriptase and integrase. J. Ethnopharmacol. 99(1): 83-91.
5. Bessong PO, Rojas LB, Obi CL, Tshisikawe PM, Igumbor EO (2006). Further screening of Venda medicinal plants for activity against HIV-1 reverse transcriptase and integrase. Afri J. Biotechnol. 5(6): 526-528.
6. Bolton EC, Mildvan AS, Boeke JD (2002). Inhibition of reverse transcription in vivo by elevated manganese ion concentration. Mol. Cell. 9(4), 879-889.
7. Bouic PJ, Clark A, Brittle W, Lamprecht JH, Freestone M, Liebenberg RW (2001). Plant sterol/sterolin supplement use in a cohort of South African HIV-infected patients-effects on immunological and virological surrogate markers. S. Afr. Med. J. 91(10): 848-850.
8. Bouic PJ (2002). Sterols and sterolins: new drugs for the immune system? Drug Discov. Today 7(14): 775-778.
9. Boyd M.R., Hallock YF., Cardellina J.H., Manfredi K.P., Blint J.W., McMahon J.B., Buckheitr R.W., Bringmann G., Schaffer M., Cragg G.M. et al. (1994). Anti-HIV michellamines from Ancistrocladus korupensis. J. Med. Chem. 37(12): 1740-1745.
10. Cos P, Hermans N, De B.T, Apers S, Sindambiwe JB, Witvrouw M, De C.E, Vandem BD, Pieters L, Vlietinck AJ (2002). Antiviral activity of Rwandan medicinal plants against human immunodeficiency virus type-1 (HIV-1). Phytomedicine 9(1): 62-68.
11. Coker AO, Isokpehi RD, Thomas BN, Amisu KO, Obi CL (2002). Human campylobacteriosis in developing countries. Emerg. Infect. Dis. 8(3): 237-244.
12. De Clercq E (2000). Current lead natural products for the chemotherapy of human immunodeficiency virus (HIV) infection. Med. Res. Rev. 20(5), 323-49.
13. el-Mekkawy S, Meselhy MR, Kusumoto IT, Kadota S, Hattori M, Namba T. (1995). Inhibitory effects of Egyptian folk medicines on human immunodeficiency virus (HIV) reverse transcriptase. Chem. Pharm. Bull. 43(4): 641-648.
14. Fennell CW, Lindsey KL, McGaw LJ, Sparg SG, Stafford GI, Elorashi EE, Grace OM, Van Staden J. (2004). Assessing African medicinal plants for efficacy and safety: pharmacological screening and toxicology. J. Ethnopharmacol. 94(2-3): 205-217.
15. Filler AG, Lever AM (1997). Effects of cation substitutions on reverse transcriptase and on human immuno deficiency virus production. AIDS Res Hum Retroviruses 13(4): 291-299.
16. Harnett SM, Oosthuizen V, van der Venter M (2005). Anti-HIV activities of organic and aqueous extracts of Sutherlandia frutescens and Lobostemon trigonus. J. Ethnopharmacol. 96(1-2): 113-119.
17. Hussein G, Miyashiro H, Nakamura N, Hattori M, Kawahata T, Otake T, Kakiuchi N, Shimotohno K (1999).Inhibitory effects of Sudanese plant extracts on HIV-1 replication and HIV-1 protease. Phytother. Res. 13(1): 31-36.
18. Kong JM, Goh NK, Chia LS, Chia TF (2003). Recent advances in traditional plant drugs and orchids. Acta. Pharmacol. Sin. 24(1): 7-21.
19. Lall N, Meyer JJ (2001). Inhibition of drug-sensitive and drug-resistant strains of Mycobacterium tuberculosis by diospyrin, isolated from Euclea natalensis. J. Ethnopharmacol. 78(2-3): 213-216.
20. Lall N, Das SM, Hazra B, Meyer JJ (2003). Antimycobacterial activity of diospyrin derivatives and a structural analogue of diospyrin against Mycobacterium tuberculosis in vitro. J. Antimicrob. Chemother. 51(2): 435-438.
21. Lattif AA, Banerjee U, Prasad R, (2004). Susceptibility pattern and molecular type of species-specific Candida in oropharyngeal lesions of Indian human immunodeficiency virus-positive patients. J. Clin. Microbiol. 42(3): 1260-1262.
22. McMichael AJ, Hanke T (2003). HIV vaccines 1983-2003. Nat. Med. 9(7): 874-880.
23. Meyer JJ, Afolayan AJ, Taylor MB, Erasmus D (1997).Antiviral activity of galangin isolated from the aerial parts of Helichrysum aureonitens. J. Ethnopharmacol. 56(2): 165-169.
24. Miller M, Cespedes C, Vavagiakis P, Klein R.S, Lowy FD (2003). Staphylococcus aureus colonization in a community sample of HIV-infected and HIV-uninfected drug users. Eur. J. Clin. Microbiol. Infect. Dis .22(8): 463-469.
25. Motsei ML, Lindsey KL, Van SJ, Jager AK (2003). Screening of traditionally used South African plants for antifungal activity against Candida albicans. J. Ethnopharmacol. 86(2-3): 235-241.
26. Pomerantz RJ, Horn DL (2003). Twenty years of therapy for HIV-1 infection. Nat. Med. 9(7), 867-873.
27. Obi CL, Potgieter N, Bessong PO, Masebe T, Mathebula H, Molobela P (2003). In vitro antibacterial activity of Venda medicinal plants. S. Afri J.Bot. 69, 199-203.
28. Obi CL, Potgieter N, Randima LP, Mavhungu NJ, Musie E, Bessonng PO, Mabogo DEN, Mashimbye J (2002). Antibacterial activity of five medicinal plants against some medically significant human bacteria. S. Afr. J. Sci. 98, 25-28.
29. Quinn TC (1997).Diversity of Campylobacter species and its impact on patients infected with human immunodeficiency virus. Clin. Infect. Dis. 24(6): 1114-1117.
30. Reid KA, Jager AK, Light ME, Mulholland DA, Van Staden J (2005). Phytochemical and pharmacological screening of Sterculiaceae species and isolation of antibacterial compounds. J. Ethnopharmacol. 97(2): 285-291.
31. Rosen S, Vincent JR, MacLeod W, Fox M, Thea DM, Simon JL (2004). The cost of HIV/AIDS to businesses in southern Africa. AIDS 18(2), 317-324.
32. Simon F, Mauclere P, Roques P, Loussert-Ajaka I, Muller-Trutwin MC, Saragosti S, Georges-Courbot MC, Barre-Sinoussi F, Brun-Vizinet F (1998). Identification of a new human immunodeficiency virus type 1 distinct from group M and group O. Nat. Med. 4(9): 1032-1037.
33. Tarrago-Litvak L, Andreola M-L, Fournier M, Nevinsky GA, Parissi V, de Soultrait VR, Litvak S (2002). Inhibitors of HIV-1 reverse transcriptase and integrase: classical and emerging therapeutical approaches. Curr. Pharm. Des. 8(8): 595-614.
34. Tshibangu KC, Worku ZB, de Jongh MA, van Wyk AE, Mokwena SO, Peranovic V (2004). Assessment of effectiveness of traditional herbal medicine in managing HIV/AIDS patients in South Africa. East Afr. Med. J. 81(10): 499-504.
35. Tshikalange TE, Meyer JJ, Hussein AA (2005).Antimicrobial activity, toxicity and the isolation of a bioactive compound from plants used to treat sexually transmitted diseases. J. Ethnopharmacol. 96(3): 515-519.
36. UNAIDS. AIDS epidemic update. Geneva, Switzerland, 2005.
37. Vlietinck AJ, De B.T, Apers S, Pieters LA (1998). Plant-derived leading compounds for chemotherapy of human immunodeficiency virus (HIV) infection. Planta. Med. 64(2): 97-109.
38. Wall ME, Wani MC, Brown DM, Fullah F, Olwald JB, Josephson FF, Thorton NM, Pezzuto JM, Beecher CWW, Farnsworth NR, Cordell GA, Kinghorn AD (1996). Effect of tannins on screening of plant extracts for enzyme inhibitory activity and techniques for their removal. Phytochemistry 3(3): 281-285.
39. Yamaguchi J, Bodelle P, Vallari AS, Coffey R, McArthur CP, Schochetman G, Devare SG, Brennan CA (2004). HIV infections in northwestern Cameroon: identification of HIV type 1 group O and dual HIV type 1 group M and group O infections. AIDS Res. Hum. Retroviruses 20(9): 944-957.
40. Zhong P, Burda S, Konings F, Urbanski M, Ma L, Zekeng L, Ewane L, Agyingi L, Agwara M, Afane ZE, Kinge T, Zolla-Pazner S, Nyambi P (2003). Genetic and biological properties of HIV type 1 isolates prevalent in villagers of the Cameroon equatorial rain forests and grass fields: further evidence of broad HIV type 1 genetic diversity. AIDS Res. Hum. Retroviruses 19(12): 1167-1178.
41. Zhu M, Phillipson JD, Greengrass PM, Bowery NE, Cai Y (1997). Plant polyphenols: biologically active compounds or non-selective binders to protein? Phytochemistry 44:441-447.